InsidersTradesSigma
Follow the 共同药业 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 共同药业 has logged 2 public disclosures. Market capitalisation: €2.6bn. The latest transaction was reported on 17 May 2024 (Sale). Among the most active insiders: 李明磊. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
共同药业是一家专注于医疗保健和制药领域的公司，在XSHE市场上市。它致力于创新药物的开发和生产。